Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026475

Options or other derivatives

  • Chief Financial Officer acquired 132,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Roche Corleen M. Chief Financial Officer 2026-03-09 Grant or award · Restricted Stock Units +132,200 132,200 D
Loading xslF345X05/tm268453-5_4seq1.xml…